← Open Payments lookup

NICOLE DEAN: Open Payments

NPI 1780218818 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$972 in 48 payments from 12 companies in 2025. Trend: 2023 $184 · 2024 $1,014 · 2025 $972

Food & beverage: $972
CompanyPaymentsAmount
ABBVIE INC.15$178
Neurocrine BioSciences, Inc.8$170
Alkermes, Inc.3$162
Axsome Therapeutics, Inc.7$160
Otsuka America Pharmaceutical, Inc.3$64
Lundbeck LLC3$61
E.R. Squibb & Sons, L.L.C.2$43
Vanda Pharmaceuticals Inc.1$38
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$35
Supernus Pharmaceuticals, Inc.2$29

Products named: VRAYLAR, INGREZZA, Auvelity, REXULTI, LYBALVI, ARISTADA, COBENFY, FANAPT.

Industry payments across AL — which companies pay providers there.